Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Shares Outstanding (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed Shares Outstanding for 7 consecutive years, with $86.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 9.17% to $86.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $86.7 million through Dec 2025, up 9.17% year-over-year, with the annual reading at $86.7 million for FY2025, 9.17% up from the prior year.
  • Shares Outstanding for Q4 2025 was $86.7 million at Strata Critical Medical, up from $86.1 million in the prior quarter.
  • The five-year high for Shares Outstanding was $86.7 million in Q4 2025, with the low at $26.1 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $73.2 million, with a median of $73.7 million recorded in 2023.
  • The sharpest move saw Shares Outstanding surged 279.87% in 2021, then grew 1.41% in 2022.
  • Over 5 years, Shares Outstanding stood at $70.7 million in 2021, then increased by 1.41% to $71.7 million in 2022, then increased by 4.84% to $75.1 million in 2023, then rose by 5.71% to $79.4 million in 2024, then increased by 9.17% to $86.7 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $86.7 million, $86.1 million, and $81.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.